Scandal hit Brazilian oil giant set to lose chief executive Maria das Graças Foster as she fails to put an end to corruption allegations during her three year rein

Part 2 of 2: Having overcome patent expirations, and accusations of corruption in China, what does the future hold for pharmaceutical giant GlaxoSmithKline Pharmaceutical? Rita Lobo explores…